Gilead and Grimstone
pay for all phase clinical trials and $30 million dollars on equity and $30 million in cash upfront. The deal was estimated to be around $785 million dollars and the sp jumped the company market cap in billions of dollars.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-140
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.004(8.33%) |
Mkt cap ! $46.91M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.6¢ | 5.2¢ | $996.9K | 16.95M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 125491 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1500000 | 1 |
View Market Depth
| Last trade - 14.10pm 19/06/2024 (20 minute delay) ? |
| BIT (ASX) Chart |